Radiopharm Theranostics Ltd
RAD
Company Profile
Business description
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
Contact
62 Lygon Street
Level 3, Carlton South
MelbourneVIC3053
AUST: +61 398245254
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,374.00 | 82.20 | -0.97% |
CAC 40 | 7,722.91 | 47.57 | -0.61% |
DAX 40 | 23,251.62 | 164.97 | 0.71% |
Dow JONES (US) | 41,317.43 | 564.47 | 1.39% |
FTSE 100 | 8,596.35 | 99.55 | 1.17% |
HKSE | 22,504.68 | 385.27 | 1.74% |
NASDAQ | 17,977.73 | 266.99 | 1.51% |
Nikkei 225 | 36,830.69 | 378.39 | 1.04% |
NZX 50 Index | 12,421.25 | 93.36 | 0.76% |
S&P 500 | 5,686.67 | 82.53 | 1.47% |
S&P/ASX 200 | 8,157.80 | 80.20 | -0.97% |
SSE Composite Index | 3,279.03 | 7.62 | -0.23% |